iShares U.S. Financials ETF (IYF) Chart & Stock Price History → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free IYF Stock Alerts $94.06 +0.32 (+0.34%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings iShares U.S. Financials ETF Stock Price Performance5 Day Performance+1.83%1 Month Performance-0.63%3 Month Performance+7.69%6 Month Performance+24.71%Year-To-Date Performance+10.22%1 Year Performance+32.97% Receive IYF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares U.S. Financials ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Unstoppable Prosperity“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. IYF Stock Chart for Wednesday, May, 8, 2024 IYF Chart by TradingView iShares U.S. Financials ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$93.61$93.74+0.14%$94.14$93.66197,319 shs$2.60 billion05/06/2024$92.48$93.61+1.22%$93.62$92.91107,297 shs$2.60 billion05/03/2024$92.12$92.45+0.36%$92.79$92.1557,407 shs$2.57 billion05/02/2024$91.67$92.12+0.49%$92.42$91.4777,388 shs$2.56 billion05/01/2024$91.15$91.67+0.57%$92.83$91.3266,972 shs$2.51 billion04/30/2024$92.16$91.15-1.10%$92.05$91.1551,218 shs$2.50 billion Get the Latest News and Ratings for IYF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares U.S. Financials ETF and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$92.17$92.16-0.01%$92.65$91.8843,769 shs$2.53 billion04/26/2024$92.49$92.17-0.35%$92.61$92.0043,087 shs$2.53 billion04/25/2024$92.96$92.49-0.51%$92.64$91.6849,775 shs$2.53 billion04/24/2024$93.15$92.96-0.20%$93.09$92.55501,384 shs$2.55 billion04/23/2024$92.67$93.15+0.52%$93.33$92.7146,609 shs$2.55 billion04/22/2024$91.30$92.67+1.50%$93.07$91.5490,064 shs$2.54 billion04/19/2024$90.09$91.30+1.34%$91.50$90.3170,036 shs$2.50 billion04/18/2024$89.49$90.09+0.67%$90.79$89.8573,187 shs$2.47 billion04/17/2024$89.42$89.49+0.08%$90.09$89.1683,553 shs$2.45 billion04/16/2024$90.00$89.42-0.64%$90.16$89.19165,148 shs$2.45 billion04/15/2024$90.55$90.00-0.61%$92.11$89.79317,261 shs$2.47 billion04/12/2024$92.11$90.58-1.66%$91.57$90.27286,008 shs$2.20 billion04/11/2024$92.78$92.11-0.72%$92.76$91.5383,991 shs$2.23 billion04/10/2024$94.26$92.78-1.57%$93.62$92.44169,397 shs$2.25 billion04/09/2024$94.74$94.26-0.51%$95.14$93.57120,802 shs$2.29 billion04/08/2024$94.24$94.74+0.53%$95.00$94.4196,637 shs$2.30 billion04/05/2024$93.54$94.24+0.75%$94.58$93.51122,085 shs$2.29 billion04/04/2024$94.53$93.54-1.05%$95.52$93.39194,261 shs$2.27 billion04/03/2024$94.47$94.53+0.06%$95.01$94.2697,098 shs$2.29 billion04/02/2024$95.03$94.47-0.59%$94.82$94.2497,605 shs$2.29 billion04/01/2024$95.65$95.03-0.65%$95.81$94.97192,277 shs$2.30 billion03/29/2024$95.65$95.65$95.88$95.2166,418 shs$2.32 billion03/28/2024$95.24$95.65+0.43%$95.88$95.2166,408 shs$2.32 billion03/27/2024$93.93$95.24+1.39%$95.24$94.2997,080 shs$2.31 billion03/26/2024$93.77$93.93+0.17%$94.19$93.7565,636 shs$2.28 billion03/25/2024$93.78$93.77-0.01%$94.10$93.68137,181 shs$2.27 billion03/22/2024$94.81$93.79-1.08%$95.00$93.7895,713 shs$2.27 billion03/21/2024$94.09$94.81+0.77%$95.04$94.1662,256 shs$2.30 billion03/20/2024$92.78$94.09+1.41%$94.19$92.5783,907 shs$2.28 billion03/19/2024$92.43$92.78+0.38%$92.95$92.4157,864 shs$2.25 billion03/18/2024$92.23$92.43+0.22%$92.60$91.9464,261 shs$2.24 billion03/15/2024$92.01$92.23+0.24%$92.53$91.5175,105 shs$2.24 billion03/14/2024$92.94$92.01-1.00%$93.04$91.5964,195 shs$2.23 billion03/13/2024$92.45$92.94+0.53%$93.11$92.5064,495 shs$2.25 billionThe Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>>03/12/2024$92.17$92.45+0.30%$92.69$92.0596,259 shs$2.24 billion03/11/2024$91.97$92.17+0.22%$92.31$91.57290,799 shs$2.24 billion03/08/2024$91.94$91.97+0.03%$92.61$91.89146,832 shs$2.23 billion03/07/2024$91.94$91.94$92.55$91.6559,091 shs$2.23 billion03/06/2024$91.52$91.94+0.46%$92.17$91.13171,573 shs$2.23 billion03/05/2024$91.36$91.52+0.18%$91.96$91.1891,376 shs$2.22 billion03/04/2024$90.79$91.36+0.63%$91.68$90.60148,858 shs$2.22 billion03/01/2024$91.00$90.79-0.23%$91.09$90.35128,895 shs$2.20 billion02/29/2024$90.79$91.00+0.23%$91.32$90.5184,907 shs$2.21 billion02/28/2024$90.51$90.79+0.31%$91.22$90.4061,483 shs$2.20 billion02/27/2024$90.18$90.51+0.37%$90.55$89.9666,078 shs$2.19 billion02/26/2024$90.56$90.18-0.42%$91.24$90.0357,984 shs$2.19 billion02/23/2024$90.28$90.56+0.31%$91.02$90.4490,886 shs$2.20 billion02/22/2024$89.31$90.28+1.09%$90.56$89.6888,932 shs$2.19 billion02/21/2024$89.20$89.31+0.12%$89.37$88.7351,427 shs$2.17 billion02/20/2024$89.30$89.20-0.11%$89.50$88.8099,203 shs$2.16 billion02/19/2024$89.30$89.30$89.73$89.1570,500 shs$2.17 billion02/16/2024$89.50$89.30-0.22%$89.73$89.1570,521 shs$2.17 billion02/15/2024$87.89$89.50+1.83%$89.72$88.77106,384 shs$2.17 billion02/14/2024$86.94$87.89+1.09%$87.96$87.3685,076 shs$2.13 billion02/13/2024$88.38$86.94-1.63%$87.78$86.2485,223 shs$2.11 billion02/12/2024$87.81$88.38+0.65%$88.82$87.75245,659 shs$2.14 billion02/09/2024$87.42$87.81+0.45%$87.86$87.2197,305 shs$2.13 billion02/08/2024$87.53$87.42-0.13%$87.60$86.8897,973 shs$2.12 billion02/07/2024$86.93$87.53+0.69%$87.63$86.65325,264 shs$2.12 billion Related Companies: KRE Stock Chart FAS Stock Chart FNCL Stock Chart KBWB Stock Chart EUFN Stock Chart KBE Stock Chart IYG Stock Chart BIZD Stock Chart IAI Stock Chart FXO Stock Chart Receive IYF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iShares U.S. Financials ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:IYF) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Financials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.